Parameters for individualizing systemic therapy in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Parameters for individualizing systemic therapy in non-small cell lung cancer

Published:2010-12 Issue:6 Volume:13 Page:196-204
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Gadgeel Shirish M.,Cote Michele L.,Schwartz Ann G.,Matherly Larry H.,Wozniak Antoinette,Bepler Gerold

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference88 articles.

1. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine;Adjei;Semin. Oncol.,2002

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl. J. Med.,2004

3. Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC);Bang;J. Clin. Oncol.,2010

4. A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region;Bepler;Genomics,1999

5. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer;Bepler;J. Clin. Oncol.,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs;Drug Resistance Updates;2023-11

2. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3;International Journal of Oncology;2019-01-24

3. Genetic Susceptibility to Lung Cancer;IASLC Thoracic Oncology;2018

4. Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma;ONCOL CLIN PRACT;2017

5. Target molecule expression profiles in metastatic renal cell carcinoma: Development of individual targeted therapy;Tissue Engineering and Regenerative Medicine;2016-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3